MedCity News July 3, 2024
Abbott recently launched the FreeStyle Libre 3 Plus sensor, which it says is the smallest and most discreet sensor on the market. It will soon be available in U.S. retail pharmacies and medical equipment suppliers.
Diabetes remains one of the nation’s most prevalent and dangerous chronic conditions, affecting nearly 15% of U.S. adults and causing more than 100,000 deaths each year. As a response, the landscape of medical devices designed to help manage this condition is evolving at a speedier tempo than ever before.
In line with this trend, Abbott unveiled the latest update to its FreeStyle Libre line of continuous glucose monitoring products last week. The medical device giant launched the FreeStyle Libre 3 Plus sensor, which it says...
Today's Sponsors
Today's Sponsor